EPISODE · Feb 4, 2016 · 13 MIN
February 2016 issue: Too many options, too little choice in COPD?
from DTB Podcast · host BMJ Group
In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the proliferation of new drugs for managing COPD; review two new lipid-lowering drugs (evolocumab and alirocumab) from a new class (proprotein convertase subtilisin/kexin type 9 inhibitors); and consider total ankle joint replacement. The DTB podcast is recorded monthly to coincide with the release of the print issue of DTB. Read all the articles featured here: http://dtb.bmj.com/content/54/2.toc
NOW PLAYING
February 2016 issue: Too many options, too little choice in COPD?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m